LexDanaLexDanabeta
Inventor

THOMAS DANIEL HEIGHTMAN

Inventor
GB

Overview

4→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes27%
C07DHeterocyclic compounds27%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
PatentTitleYear
12,091,409Ether linked triazoles as NRF2 activators202411,939,321Benzolactam compounds as protein kinase inhibitors202411,866,428Bicyclic heterocycle compounds and their uses in therapy202411,786,600Cliptac composition2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to OTSUKA PHARMA CO LTD (2)· patent assignee history
2023–2024Based in GB· patent location history
2024Patents assigned to ASTEX THERAPEUTICS LTD (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASTEX THERAPEUTICS LTD22024
OTSUKA PHARMA CO LTD22023–2024
Locations
LocationPatentsSpan
GB42023–2024